Company Filing History:
Years Active: 1976-1988
Title: James Guthrie Hamilton: Innovator in Thromboxane Synthase Inhibitors
Introduction
James Guthrie Hamilton is a notable inventor based in Nutley, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of thromboxane synthase inhibitors. With a total of 7 patents to his name, Hamilton's work has the potential to impact the treatment of obesity and insulin resistance.
Latest Patents
Hamilton's latest patents focus on the use of thromboxane synthase inhibitors as insulin-lowering agents. These compounds are categorized into various classes, including 1-substituted imidazoles, 4-substituted imidazoles, 3-substituted pyridines, 3-substituted indoles, 4-substituted pyrimidines, 5-substituted tetrazoles, pyrazolidines, quinazolines, and substituted xanthene carboxylic acids. His research also emphasizes the application of these inhibitors as antiobesity agents, showcasing their dual functionality in addressing metabolic disorders.
Career Highlights
Hamilton is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work at the company has allowed him to explore innovative solutions to complex health issues. His dedication to research and development has positioned him as a key figure in his field.
Collaborations
Some of Hamilton's notable coworkers include Ann C Sullivan and Lawrence D Tobias. Their collaborative efforts contribute to the advancement of research in the pharmaceutical sector.
Conclusion
James Guthrie Hamilton's innovative work in thromboxane synthase inhibitors highlights his commitment to improving health outcomes. His contributions to the field are significant and continue to pave the way for future advancements in medical treatments.